From: Forces influencing generic drug development in the United States: a narrative review
Education | Educational materials: treatment guidance and educational outreach visit |
Engineering | Organizational interventions: agreements on price and volume of existing drugs |
Economics | Financial incentives: positive and negative incentives for physicians |
Enforcement | Regulatory or law enforcement: mandatory generic substitution laws |